Q: What is Latisse?

A:  Bimatoprost ophthalmic solution 0.03% was initially developed and used for over 10 years as a glaucoma medication.  In using the medication many patients noticed that their eyelashes grew.  Many even had to trim their lashes due to excessive length.  Allergan, who owned the medication, began to market the medication for topical use in patients with hypotrichosis (small lashes).  The new medications name is Latisse.

Q: How long has Latisse been on the market?

A: Latisse has been available for over 6 months.  But its safety record, as an eye drop solution, is well over 10 years.  Any medication that is used in the eye must be very safe.

Read full Q&A via  Hess Plastic Surgery.